Аbout Lumier

LUMIER PHARMA LLC - domestic manufacturer of medicines. The company was founded in 2009 in Kyiv (Ukraine). "LUMIER PHARMA" LLC holds License for Manufacture of Medical Products series AB № 578997, License for the import of medicines of AE series No. 192374 and Certificate of GMP compliance №060/2021/GMP.

• capsules, tablets, coated tablets, granules, coated granules;
• solutions for infusions, solutions for injections;
• concentrates for preparation of infusion solutions;
• lyophilized powders for preparation of injection solutions with solvents, lyophilizates for preparation of infusion solutions, lyophilizates for preparation of injection solutions;
• powders for preparation of injection solutions, powders for preparation of infusion solutions.

LUMIER PHARMA LLC provides medicines and medical-purpose goods packing and repacking services in conformity with Ukrainian legislation and EU GMP requirements.

The company’s top-priority efforts are directed at the establishment and development of long-term partner relations with the world’s leading pharmaceutical companies within the framework of the import substitution policy in Ukraine aimed at the improvement of accessibility of high quality medicines for all patients. In 2010, work was commenced on the implementation of the mutual social project launched in collaboration with the global pharmaceuticals manufacturer, F.Hoffmann-La Roche Ltd, aimed at the production of the following biotechnological medicines in Ukraine: PEGFERON (PEG-interferon alpha-2a)for the treatment of chronic viral hepatitis (B and C), RITUXIM (rituximab) for the treatment of non-Hodgkin's lymph, chronic lymphatic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis, TRASTUMAB (trastuzumab) for the treatment of HER-2 positive metastatic or early breast cancer.

Company Mission

LUMIER PHARMA - domestic manufacturer of pharmaceuticals, pursues the mission of providing the residents of Ukraine with groundbreaking import-substituting high-quality medications designated for the treatment of socially significant and societally hazardous diseases in conformity with internationally established treatment standards.

Anticorruption policy of the company

The company has introduced Anticorruption policy , the provisions of which apply to all employees of the Company. The policy is intended to emphasize the standards and principles that should determine the behavior of the Company's employees to comply with the rules of anti-corruption laws and laws on combating bribery.